L&T Technology Services
update
QOQ
REVENUE up 6% - 1449.5 cr vs 1370 cr
NP up 12% - 186cr vr 165.5cr
YOY Decreasing
Q3FY21
Rev Down 1.5% YOY
1400.7cr VS 1423cr
EBITDA 275 cr VS 286cr
EBITDA MARGIN # 18%
PAT Down 9% YOY
186 cr vs 204 cr,
EPS # 17.97 vs 18.79
QoQ
Reults is Improving
9M Ended EPS # 45.79 vs 56.85
Strong Cashflows
Concentration risk going down
Transportation & Plant engineering remain in stress (down 20%)
Telecom & Medical devices had a recovery.
During the quarter, LTTS won 7 deals with TCV of USD10 million plus, which includes a USD100 million plus deal and 2 USD15 million plus deals. Revenues from digital and leadingedge technologies stood at 49% during the quarter.
"We had a strong performance with sequential improvement in both revenue and operating margin. All five of our industry segments grew sequentially, with three segments recording growth of 5% plus. Deal wins were especially strong in the quarter helped by a marquee USD100M plus engagement with an O&G major - a validation of our best-in-class domain expertise and deep customer relationships.
The deal pipeline is healthy across segments as customers prioritize business transformation to improve efficiency and productivity. We are leveraging newer technologies like Digital Thread, IoT and AI to further our positioning as innovation partners to our customers. I would like to highlight that the strong uptick in Industrial Products has been led by deals involving digital led transformational programs", said Dr. Keshab Panda, CEO & Managing Director, L&T Technology Services Limited.
update
QOQ
REVENUE up 6% - 1449.5 cr vs 1370 cr
NP up 12% - 186cr vr 165.5cr
YOY Decreasing
Q3FY21
Rev Down 1.5% YOY
1400.7cr VS 1423cr
EBITDA 275 cr VS 286cr
EBITDA MARGIN # 18%
PAT Down 9% YOY
186 cr vs 204 cr,
EPS # 17.97 vs 18.79
QoQ
Reults is Improving
9M Ended EPS # 45.79 vs 56.85
Strong Cashflows
Concentration risk going down
Transportation & Plant engineering remain in stress (down 20%)
Telecom & Medical devices had a recovery.
During the quarter, LTTS won 7 deals with TCV of USD10 million plus, which includes a USD100 million plus deal and 2 USD15 million plus deals. Revenues from digital and leadingedge technologies stood at 49% during the quarter.
"We had a strong performance with sequential improvement in both revenue and operating margin. All five of our industry segments grew sequentially, with three segments recording growth of 5% plus. Deal wins were especially strong in the quarter helped by a marquee USD100M plus engagement with an O&G major - a validation of our best-in-class domain expertise and deep customer relationships.
The deal pipeline is healthy across segments as customers prioritize business transformation to improve efficiency and productivity. We are leveraging newer technologies like Digital Thread, IoT and AI to further our positioning as innovation partners to our customers. I would like to highlight that the strong uptick in Industrial Products has been led by deals involving digital led transformational programs", said Dr. Keshab Panda, CEO & Managing Director, L&T Technology Services Limited.
Wealthcreatures.com
PORTFOLIO BUILDING STOCK 🎯HDFC AMC 🎯 STRONG BRAND VERY STRONG BUSSINESS CMP - 2440 ACCMULATION ZONE - 2300 TO 2440 EXPECTED CROSS ALL TIME HIGH OF 3800+ IN NEXT 12 TO 24 MONTHS
HDFC AMC
GOOD Q3 NUMBERS
READY FOR NEW 52WK HIGH VERY 🔜
GOOD Q3 NUMBERS
READY FOR NEW 52WK HIGH VERY 🔜
Wealthcreatures.com
#InvestmentPick HDFCLife Accumulate: 535-650 SL : 615 T : 700/720
HDFCLIFE
Update SL to 565 DCB
Can add some Quantity here as well for Investment with Target of 800
Update SL to 565 DCB
Can add some Quantity here as well for Investment with Target of 800
https://wealthcreatures.com/2020/03/25/visaka-inds-can-past-glory-of-stock-return-back-in-next-5-year-again-only-time-would-tell/
VISAKA INDS
ALREADY 4.5X MULTIBAGGER TILL NOW
94 TO 419.90 TILL NOW
STOCK HAD A GOOD RANGE BOUND CONSOLIDATION BWT 330 TO 380 ZONE FROM LAST 3 MONTHS
TODAY BIG BREAKOUT ABOVE 400
NEXT LEG OF RALLY TILL 444/500/555+++
VISAKA INDS
ALREADY 4.5X MULTIBAGGER TILL NOW
94 TO 419.90 TILL NOW
STOCK HAD A GOOD RANGE BOUND CONSOLIDATION BWT 330 TO 380 ZONE FROM LAST 3 MONTHS
TODAY BIG BREAKOUT ABOVE 400
NEXT LEG OF RALLY TILL 444/500/555+++
WealthCreatures
VISAKA INDS – Can Past Glory of Stock Return Back in next 5 Year Again? Only Time would Tell
Cmp – 94 52Wk High/Low – 448/94 5 Year High/Low – 838/85 MARKET CAP – 154 cr FACE VALUE – 10 DIVIDEND YIELD – 7.20% BOOK VALUE – 314 FY 20 EXPECTED EPS …
Wealthcreatures.com
CAMS 1405 TO 1890 NOW TRADING @1789 Add on dips near 1700-1600 If one has patience This can give Huge RETURNS LONGTERM TEST LEVELS # 2500/2750/3000/3300++ FEW FACTS Paid up Equity: 49 Cr Face Value: 10 Long Term Borrowings: Nil Short Term Borrowings:…
CAMS
AGAIN ON RADAR
READY FOR NEW 52WK HIGH
KEEP 👀
AGAIN ON RADAR
READY FOR NEW 52WK HIGH
KEEP 👀
MARKETS ARE AT HIGH
NIFTY ALL TIME HIGH
SENSEX ALL TIME HIGH
ONE SHOULD PLAY VERY SAFE & TIME TO BE VERY CAUTIOUS NOW AS RISK REWARD IS NOT FAVOURABLE IN MARKETS
BIG EVENT BUDGET IS COMING on 1st FEB'2021
BUDGET CAN BE SECTOR SPECIFIC & STOCK SPECIFIC
DONT BE GREEDY ( STOCKS WHERE YOU ARE IN GOOD PROFITS) - BOOK ATLEST PARTIAL IF NOT WHOLE PROFITS
KEEP BOOKING PROFITS AS PER RISK
Those PLAYing STOCK SPECIFIC PLAY WITH STRICT S/L
KEEP BOOKING PROFITS AS PER RISK
NIFTY & SENSEX BOTH IN NEW ZONE
NIFTY POSSIBLE TEST LEVELS # 14850/14980/15000 ALSO
SENSEX CAN ALSO TEST # 51000/52000 IN NEAR TERM
NIFTY ALL TIME HIGH
SENSEX ALL TIME HIGH
ONE SHOULD PLAY VERY SAFE & TIME TO BE VERY CAUTIOUS NOW AS RISK REWARD IS NOT FAVOURABLE IN MARKETS
BIG EVENT BUDGET IS COMING on 1st FEB'2021
BUDGET CAN BE SECTOR SPECIFIC & STOCK SPECIFIC
DONT BE GREEDY ( STOCKS WHERE YOU ARE IN GOOD PROFITS) - BOOK ATLEST PARTIAL IF NOT WHOLE PROFITS
KEEP BOOKING PROFITS AS PER RISK
Those PLAYing STOCK SPECIFIC PLAY WITH STRICT S/L
KEEP BOOKING PROFITS AS PER RISK
NIFTY & SENSEX BOTH IN NEW ZONE
NIFTY POSSIBLE TEST LEVELS # 14850/14980/15000 ALSO
SENSEX CAN ALSO TEST # 51000/52000 IN NEAR TERM
*SBI Cards and Payment Services*
The company has reported profit at Rs 209.65 crore in Q3FY21 against Rs 434.66 crore in Q3FY20
Revenue fell to Rs 2,403.2 crore from Rs 2,479.1 crore YoY.
The company has reported profit at Rs 209.65 crore in Q3FY21 against Rs 434.66 crore in Q3FY20
Revenue fell to Rs 2,403.2 crore from Rs 2,479.1 crore YoY.
Wealthcreatures.com
1 MORE I.T STOCK LOOKING GOOD FOR ACCMULATION ZENSAR TECH CMP - 181 Accmulation # 170 To 181 Support @ 168/165 CAN TEST # 190/200/225/240++ TF - 1/3/6 months S/L # As per Risk or 2% Below support Levels.
Zensar Technologies
Very Good Numbers
The company reported consolidated profit at Rs 137.9 crore in Q3FY21 against Rs 50 lakh in Q2FY21, revenue fell to Rs 934.4 crore from Rs 979.4 crore QoQ.
Very Good Numbers
The company reported consolidated profit at Rs 137.9 crore in Q3FY21 against Rs 50 lakh in Q2FY21, revenue fell to Rs 934.4 crore from Rs 979.4 crore QoQ.
In FOCUS
SARDA ENERGY & Minerals
Cmp - 360
Q3 FY21 EXPECTED to be good.
FY21 Expexted EPS 90 To 95.
Stock Trading cheap only at PE of 3.78
SUPPORT @320/310
ONE CAN ADD NEAR SUPPORT ONLY.
POSSIBLE STOCK can Give 30% To 50% Upside in next 6 to 12 months.
S/L - As per Risk on Below support levels
Disc - All views expressed are personal and only for educational and study purpose only. Consult your financial advisor before investing or taking any position based on above article.
SARDA ENERGY & Minerals
Cmp - 360
Q3 FY21 EXPECTED to be good.
FY21 Expexted EPS 90 To 95.
Stock Trading cheap only at PE of 3.78
SUPPORT @320/310
ONE CAN ADD NEAR SUPPORT ONLY.
POSSIBLE STOCK can Give 30% To 50% Upside in next 6 to 12 months.
S/L - As per Risk on Below support levels
Disc - All views expressed are personal and only for educational and study purpose only. Consult your financial advisor before investing or taking any position based on above article.
Wealthcreatures.com
CYIENT CMP - 379 BOOK VALUE - 232 DIVIDEND YIELD - 3.9% Accmulation- 350 TO 379 ZONE Support - 335 COMPANY CAN POST RS.35 TO 37 EPS FOR FY21. IN NEXT 1 TO 2 QTR STOCK CAN TEST ITS 52wk HIGH OF 513 Won't be suprised To See 600++ in next 12 to 18…
CYIENT
VERY GOOD Q3 NUMBERS
PAT UP 13%
95cr vs 84cr
Stock up 8%
548
VERY GOOD Q3 NUMBERS
PAT UP 13%
95cr vs 84cr
Stock up 8%
548
Today results of our picks
RIL
KOPRAN
MANGALAM ORGANIC
HDFC LIFE
GLAND PHARMA
RIL
KOPRAN
MANGALAM ORGANIC
HDFC LIFE
GLAND PHARMA
Wealthcreatures.com
CYIENT CMP - 379 BOOK VALUE - 232 DIVIDEND YIELD - 3.9% Accmulation- 350 TO 379 ZONE Support - 335 COMPANY CAN POST RS.35 TO 37 EPS FOR FY21. IN NEXT 1 TO 2 QTR STOCK CAN TEST ITS 52wk HIGH OF 513 Won't be suprised To See 600++ in next 12 to 18…
CYIENT 💚💚
NOW BLASTING
15%
NEW 52WK HIGH
584.85
379 TO 584.85 TILL NOW
NOW BLASTING
15%
NEW 52WK HIGH
584.85
379 TO 584.85 TILL NOW